logo

For the Inventor, By the Inventor

Osaka, Japan

Kohji Hanasaki

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignee: Shionogi Company Limited. Active years: 2003-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohji Hanasaki. Retrieved from https://idiyas.com/inventor/kohji-hanasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 15.4

 

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 151(Granted Patents)


Location History:

  • Kyoto, JP (2003 - 2004)
  • Osaka, JP (2004 - 2012)

Company Filing History:

goldMedal13 out of 1,001 
 
Shionogi Company Limited
 patents

Years Active: 2003-2012

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 8115027 - NPY Y5 antagonist (2012-02-14),
2. 8088924 - Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor (2012-01-03),
3. 7652141 - Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor (2010-01-26),
4. 7265130 - NPY Y5 antagonist (2007-09-04),
5. 7026318 - [object Object] (2006-04-11),
6. 6977266 - Pyridone derivatives having affinity for cannabinoid 2-type receptor (2005-12-20),
7. 6967200 - Remedies for cirrhosis (2005-11-22),
8. 6967095 - Human secretory type phospholipase A2 (2005-11-22),
9. 6872557 - Gene encoding novel human secretory phospholipase A2 (2005-03-29),
10. 6756219 - Human secretory type phospholipase a2 (2004-06-29),
11. 6743923 - Antirheumatic agent (2004-06-01),
12. 6699891 - Npyy5 antagonists (2004-03-02),
13. 6525081 - Antirheumatic (2003-02-25),

Title: Kohji Hanasaki: Innovator in Pharmaceutical Chemistry

Introduction

Kohji Hanasaki is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 13 patents. His work focuses on developing innovative compounds that target specific receptors in the human body.

Latest Patents

Among his latest patents is a pharmaceutical composition for use as an NPY Y5 receptor antagonist. This invention comprises a compound represented by a specific formula, which aims to provide therapeutic benefits. Another notable patent involves pyridone derivatives that exhibit binding activity to the cannabinoid type 2 receptor. This compound is characterized by a complex formula that includes various substituents, showcasing Hanasaki's expertise in medicinal chemistry.

Career Highlights

Kohji Hanasaki is currently employed at Shionogi & Company Limited, where he continues to advance his research and development efforts. His work at Shionogi has positioned him as a key player in the pharmaceutical industry, contributing to the development of new therapeutic agents.

Collaborations

Hanasaki collaborates with esteemed colleagues, including Yasuyuki Kawanishi and Hideyuki Takenaka. These partnerships enhance the innovative potential of his research and contribute to the success of their projects.

Conclusion

Kohji Hanasaki's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His ongoing work promises to impact the development of new treatments and therapies in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…